LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

Inicio・Lista de Acciones・Teleflex Inc

Teleflex Inc

Abierto

SectorSanidad

133.88 -0.42

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

130.29

Máximo

134.99

Métricas clave
By Trading Economics
Ingresos	405M -3.6M
Ventas	-344M 569M
P/B Media del Sector	92.938 49.8
Rentabilidad por dividendo	1.12
Margen de beneficios	-0.624
Empleados	15,500
EBITDA	339M 16M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+12.45% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	1.12% 2.25%
Próximas Ganancias	30 jul 2026
Fecha Próximo Dividendo	15 jun 2026
Próxima Fecha de Ex Dividendo	19 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	311M 5.3B
Apertura anterior	134.3
Cierre anterior	133.88

Noticias sobre sentimiento de mercado

By Acuity

33%

67%

94 / 347 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

122.73 / 135.75 Soporte y Resistencia

Teleflex Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 may 2026, 23:58 UTC

Ganancias

OCBC's First-Quarter Net Profit Rose on Record Noninterest Income

7 may 2026, 22:57 UTC

Ganancias

Australia's Macquarie Beats Consensus With 30% Fiscal Year Profit Jump

7 may 2026, 23:52 UTC

Ganancias

CoreWeave Stock Dives on Weak Outlook -- Barrons.com

7 may 2026, 23:45 UTC

Charlas de Mercado

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

7 may 2026, 23:39 UTC

Charlas de Mercado

Gold Rises on Signs of Ongoing U.S.-Iran Tensions -- Market Talk

7 may 2026, 23:28 UTC

Charlas de Mercado

Australian Budget Set to Contain A$64B in Spending Cuts-- Market Talk

7 may 2026, 23:11 UTC

Ganancias

OCBC Group CEO: Well-Positioned to Navigate Uncertainties, Deliver Sustainable Long-Term Value >O39.SG

7 may 2026, 23:06 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net Interest Margin 1.76%, Down 28 Bps on Year >O39.SG

7 may 2026, 23:05 UTC

Ganancias

Oversea-Chinese Banking Corp.: Solid 1Q Performance Underpinned by Record Non-Interest Income >O39.SG

7 may 2026, 23:04 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Non-Interest Income S$1.61B Vs. S$1.31B >O39.SG

7 may 2026, 23:03 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.22B Vs. S$2.35B >O39.SG

7 may 2026, 23:03 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net S$1.97B Vs. Net S$1.88B >O39.SG

7 may 2026, 23:02 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Total Income S$3.83B Vs. S$3.66B >O39.SG

7 may 2026, 23:00 UTC

Charlas de Mercado

Australia's Federal Budget Likely to Contain Significant Reforms -- Market Talk

7 may 2026, 22:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 may 2026, 22:45 UTC

Charlas de Mercado

Lyft Says Efforts to Service Waymo's AVs Are Underway -- Market Talk

7 may 2026, 22:42 UTC

Ganancias

Australia's Macquarie Beats Consensus With 30% FY Profit Jump

7 may 2026, 22:33 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Gilead Stock Falls. A Massive Acquisition Spree Is Coming at a Cost. -- Barrons.com

7 may 2026, 22:32 UTC

Ganancias

Macquarie FY Total Customer Deposits A$221.5B Vs. A$177.7B>MQG.AU

7 may 2026, 22:31 UTC

Ganancias

Macquarie FY Return on Equity 14.0% Vs. 11.2%>MQG.AU

7 may 2026, 22:31 UTC

Ganancias

Macquarie: 68% of FY Income From International >MQG.AU

7 may 2026, 22:30 UTC

Ganancias

Macquarie Bank Year-End CET1 Level 2 Ratio 12.8%>MQG.AU

7 may 2026, 22:30 UTC

Ganancias

Macquarie Capital Surplus A$9.3B at March 31 Vs. A$9.5B a Year Earlier>MQG.AU

7 may 2026, 22:29 UTC

Ganancias

Macquarie CEO: Well-Positioned for Superior Medium-Term Performance>MQG.AU

7 may 2026, 22:28 UTC

Ganancias

Macquarie: Continues a Conservative Approach to Capital, Funding, Liquidity>MQG.AU

7 may 2026, 22:28 UTC

Ganancias

Macquarie: Continues to Maintain a Cautious Stance>MQG.AU

7 may 2026, 22:27 UTC

Ganancias

Macquarie: Decision Recognizes Prevailing Market Conditions>MQG.AU

7 may 2026, 22:27 UTC

Ganancias

Macquarie Has Not Purchased Shares Since Extending the Buyback>MQG.AU

7 may 2026, 22:26 UTC

Ganancias

Macquarie to End Share Buyback Extended in November>MQG.AU

7 may 2026, 22:25 UTC

Ganancias

Macquarie Commodities and Global Markets FY Net Profit Contribution A$4.2B, Up 49% on Year>MQG.AU

Comparación entre iguales

Cambio de precio

Teleflex Inc previsión

Precio Objetivo

By TipRanks

12.45% repunte

Estimación a 12 Meses

Media 138.57 USD 12.45%

Máximo 155 USD

Mínimo 128 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Teleflex Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

Comprar

Mantener

Vender

De acuerdo con 7 analistas que ofrecen calificaciones bursátiles a para Teleflex Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

122.73 / 135.75Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

There are no events.

Sentimiento

By Acuity

94 / 347 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.